Back to discover
Disease

Dermatitis, Phototoxic

Late-stage therapeutic developmentEmerging research
1
Publications
1
Clinical trials
2010
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

No activity recorded in this window. Try a wider timeframe.

Clinical trials

1 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
1
All trials
0
Active
1
Late-stage
1
Completed
Late-stage studies

HT201308- Human Phototoxicity Test

Phase 3 · Completed · Bayer
Recently completed

HT201308- Human Phototoxicity Test

Phase 3 · Completed · Bayer

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Most influential
Recent publications
Major themes2
  • Ecotoxicology1
  • Risk Assessment1
Leading journals1
  • Environmental toxicology and chemistry1
Leading researchers8
  • Ankley GT1
  • Bennett RS1
  • Erickson RJ1
  • Hoff DJ1
  • Hornung MW1
  • Johnson RD1
  • Mount DR1
  • Nichols JW1
Affiliations (unnormalised)1
  • National Health and Environmental Effects Research Laboratory1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

A nonimmunologic, chemically induced type of photosensitivity producing a sometimes vesiculating dermatitis. It results in hyperpigmentation and desquamation of the light-exposed areas of the skin.

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.